Precision Neuroscience focuses on developing advanced neurotechnology aimed at addressing neurological disorders and enhancing brain function. Their primary innovation is a brain-computer interface (BCI) that enables direct communication between the brain and external devices. This technology is designed to facilitate rehabilitation for individuals with neurological impairments, allowing for improved motor control and cognitive function. The company emphasizes the importance of precision in their approach, utilizing sophisticated algorithms and real-time data processing to tailor interventions to individual patient needs.

In addition to their BCI, Precision Neuroscience is also exploring various applications of neuromodulation techniques. These methods involve the use of electrical stimulation to influence neural activity, potentially offering new treatment avenues for conditions such as epilepsy, depression, and chronic pain. The company is committed to advancing the understanding of brain function through rigorous scientific research, aiming to translate their findings into practical solutions that can significantly improve the quality of life for patients with neurological challenges.

United States

Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from neurological illnesses. We are building the only brain–computer interface that is designed to be minimally invasive, safely removable, and capable of processing large amounts of data. 

Precision Neuroscience

Company Details